Tylenol Autism Lawsuit 

The Tylenol autism case has sparked national interest. This statewide legal action, the Acetaminophen Autism Lawsuit, can potentially be the largest mass tort in U.S. history. Consult the Law Office of Brian P. Azemika to know more. 

What is the Tylenol Autism lawsuit? 

The Tylenol Autism Lawsuit is a huge class action lawsuit filed in the United States by parents who allege that taking Tylenol during pregnancy caused their kid to be diagnosed with autism, ADHD, or other neurological issues. Here are the fundamental facts you need to know to establish your eligibility for a Tylenol-autism lawsuit settlement.

Numerous product liability cases have been filed against the producers of Tylenol and generic acetaminophen (commonly known as Paracetamol, its chemical name). According to these mass tort cases, the product’s producers and merchants are accused of failing to notify pregnant women, doctors, and the general public about a possible risk that occurs when the goods are used during pregnancy.

Taking acetaminophen during pregnancy has been associated with a 20% to 30% increase in children diagnosed with autism spectrum disorder (ASD), ADHD (attention deficit hyperactivity disorder), hyperactivity, and other conduct-related issues. The most researched relationship is between Tylenol and autism. The quantity of the research, consistent methodology, and “robust” study designs give substantial evidence and a compelling case that paracetamol usage during pregnancy increases the likelihood of neurodevelopmental disorder diagnosis in children.

Tylenol Autism lawsuit updates – June 2023 

  • June 1, 2023 

Only six new cases have been added to the class action MDL in the preceding month. So far, 124 Tylenol lawsuits have been filed. The prospective plaintiff pool, in this case, is vast, so why has the MDL stayed so small?

The reason for this is that most potential plaintiffs have chosen to sit on the sidelines until the MDL judge rules on the admission of causation evidence. If Judge Cote determines that the plaintiffs’ scientific evidence is inadmissible, all MDL cases would be dismissed and there will be no opportunity to re-file. However, plaintiffs who delay filing can file in state court if the Daubert decision does not go their way.

Plaintiffs who avoid federal court can nonetheless file claims in state court. This litigation strategy will work well because the statute of limitations is less of a problem in most Tylenol disputes.

  • June 4, 2023 

J&J intends to pursue the scientists who found that Tylenol causes autism. The business served these scientists with nine subpoenas. The plaintiffs have filed to quash the subpoena, claiming that the subpoena’s late and onerous request for nine depositions without prior warning is not how the legal process should function.